Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

835 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT07365241

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063 Birmingham, Alabama, United States
  • Usa Mitchell Cancer Institute /ID# 280198 Mobile, Alabama, United States
  • City Of Hope - Phoenix /ID# 281323 Goodyear, Arizona, United States
  • City of Hope National Medical Center /ID# 281322 Duarte, California, United States
View all 72 locations
View Trial Details
Recruiting

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Genital Diseases, +28 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

NCT07488676

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +15 more
Locations
  • UAB Medicine - UAB Hospital Birmingham, Alabama, United States
  • START Los Angeles Los Angeles, California, United States
  • Indiana University (IU) Health - Multi-D Oncology Clinic Indianapolis, Indiana, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 21 locations
View Trial Details
Recruiting

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

NCT07278479

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • United Theranostics Glen Burnie, Maryland, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • United Theranostics Princeton, New Jersey, United States
View Trial Details
Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

NCT07006727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • University Of Iowa Iowa City, Iowa, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Corewell Health William Beaum Hosp Royal Oak, Michigan, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

NCT05983432

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope Cancer Center Duarte, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Santa Monica Santa Monica, California, United States
View all 37 locations
View Trial Details
Recruiting

Study of Trilaciclib and Lurbinectidin

NCT05578326

Conditions
Agranulocytosis, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
Locations
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details

Related conditions